Journal «Angiology and Vascular Surgery» • 

2012 • VOLUME 18 • №2

Comparison of remote results outcomes of stenting and eversion endarterectomy from internal carotid arteries

Sidorov A.A.1, Kokov L.S.2, Beloyartsev D.F.1, Tsygankov V.N.1, Shutikhina I.V.1, Goncharov A.I.1

1) Department of Vascular Surgery A.V. Vishnevsky Institute of Surgery Ministry of Public Health and Social Development of the Russian Federation
2) Scientific Research Institute of Emergency Ambulance Care named after N.V. Sklifosovsky,
Moscow Healthcare Department, Moscow, Russia

Presented in the article are comparative results of carotid angioplasty with stenting (CAS) and eversion carotid endarterectomy (ECEA) in the remote period of follow up.

The study included a total of 92 patients. Of these, 33 were subjected to CAS (Group I) and 59 underwent a total of 63 ECEAs (Group II). Depending upon the presence or absence of symptoms of cerebrovascular insufficiency (CVI), as well as based on assessment of risk factors for surgical intervention, the patients were subdivided into four subgroups: a) low-risk asymptomatic b) low-risk symptomatic, c) high-risk asymptomatic and d) high-risk symptomatic.

We followed up remote results in 31 Group I patients (94%) up to 70 months (mean period of follow up amounted to 25±17 months), and in 36 Group II patients up to for up to 65 months (mean duration of the follow up amounting to 37±20 months). There was no statistically significant difference (P >0.05) between subgroups of patients along such parameters as severe or mild stroke, myocardial infarction, stroke-related death, or myocardial infarction related death.

CAS and ECEA are equally highly efficient techniques of preventing acute cerebral circulation impairments in the remote period of follow up in patients of both high and low risk of surgical intervention.

KEY WORDS: carotid angioplasty with stenting, eversion carotid endarterectomy, acute cerebral circulation impairment, remote period of follow up.

P. 124-129

« Back

Angiologia.ru - portal for professionals
VLAANT
Lancet
HI-TECHNOLOGY MEDICINE